查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538491

酵母感染疾病治療市場報告：2030 年趨勢、預測與競爭分析

Yeast Infection Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

酵母菌感染疾病治療的趨勢與預測

到 2030 年，全球酵母菌感染疾病治療市場預計將達到 79 億美元，2024 年至 2030 年複合年成長率為 4.6%。這個市場的主要促進因素是自體免疫疾病和酵母菌感染疾病的增加、感染疾病和過敏性疾病發病率的顯著上升以及政府對酵母菌感染疾病創新療法的資助增加。全球酵母菌感染疾病治療市場的未來看起來充滿希望，零售藥局/藥局、醫院藥局、專賣店和線上銷售市場都有機會。

酵母菌感染疾病的細分治療

這項研究包括按治療類型、適應症、劑型、分銷管道和地區對全球酵母菌感染疾病治療的預測。

酵母感染疾病治療市場洞察

Lucintel 預計錠劑/膠囊由於其尺寸多樣且保存期限長，在預測期內仍將是最大的細分市場。

在這個市場中，零售藥局/藥局將繼續成為最大的細分市場。

由於感染疾病和酵母菌感染疾病的頻率不斷增加，北美在預測期內可能仍然是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球酵母菌感染疾病治療市場預計將達到 79 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球酵母菌感染疾病治療市場預計將以4.6%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是自體免疫疾病和酵母菌感染疾病的增加、感染疾病和過敏性疾病發病率的顯著上升以及政府對酵母菌感染疾病創新治療的資助增加。

Q4.市場的主要細分市場是：

A4. 全球酵母菌感染疾病治療市場前景廣闊，零售藥局/藥局、醫院藥局、專賣店和線上銷售市場都有機會。

Q5.市場的主要企業是：

A5. 主要的酵母菌感染疾病治療公司有：

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，錠劑/膠囊由於尺寸多樣且保存期限長，在預測期內將繼續成為最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於感染疾病地區陰道和感染疾病的頻率不斷增加，在預測期內，北美將繼續成為最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球酵母感染疾病治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球酵母感染疾病治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按治療類型分類的全球酵母感染疾病治療市場
    • Azole
    • 多基因
    • Echinocandins
    • 其他
  • 按適應症分類的全球酵母感染疾病治療市場
    • 生殖器念珠菌症
    • 侵襲性念珠菌症
    • 口咽/食道念珠菌症
    • 其他
  • 全球酵母感染疾病治療市場（按劑型）
    • 粉末
    • 乳膏/軟膏
    • 錠劑/膠囊
    • 其他
  • 按分銷管道分類的全球酵母感染疾病治療市場
    • 零售藥局/藥局
    • 醫院藥房
    • 專賣店
    • 網上銷售
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球酵母感染疾病治療市場（按地區）
  • 北美酵母感染疾病治療市場
  • 歐洲酵母感染疾病治療市場
  • 亞太酵母感染疾病治療市場
  • 其他地區酵母菌感染疾病治療市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球酵母感染疾病治療市場成長機會（依治療類型）
    • 全球酵母感染疾病治療市場成長機會（按適應症）
    • 全球酵母感染疾病治療市場成長機會（按劑型）
    • 全球酵母感染疾病治療市場成長機會（按分銷管道）
    • 全球酵母感染疾病治療市場按地區成長機會
  • 全球酵母菌感染疾病治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球酵母感染疾病治療市場的產能擴張
    • 全球酵母菌感染疾病治療市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer
簡介目錄

Yeast Infection Treatment Trends and Forecast

The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets. The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Yeast Infection Treatment by Segment

The study includes a forecast for the global yeast infection treatment by treatment type, indication, form, distribution channel, and region.

Yeast Infection Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Azoles
  • Polygene
  • Echinocandin
  • Others

Yeast Infection Treatment Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Genital Candidiasis
  • Invasive Candidiasis
  • Oropharyngeal/Esophageal Candidiasis
  • Others

Yeast Infection Treatment Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Powders
  • Creams/Ointments
  • Tablets/Capsules
  • Others

Yeast Infection Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacies/Drug Stores
  • Hospital Pharmacies
  • Specialty Stores
  • Online Sales
  • Others

Yeast Infection Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Yeast Infection Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies yeast infection treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the yeast infection treatment companies profiled in this report include-

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Yeast Infection Treatment Market Insights

Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Within this market, retail pharmacy/drug store will remain the largest segment.

North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Features of the Global Yeast Infection Treatment Market

Market Size Estimates: Yeast infection treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Yeast infection treatment market size by treatment type, indication, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Yeast infection treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment type, indication, form, distribution channel, and regions for the yeast infection treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the yeast infection treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the yeast infection treatment market size?

Answer: The global yeast infection treatment market is expected to reach an estimated $7.9 billion by 2030.

Q2. What is the growth forecast for yeast infection treatment market?

Answer: The global yeast infection treatment market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the yeast infection treatment market?

Answer: The major drivers for this market are increase in autoimmune disorders and yeast infections, significant rise in the incidence of infectious diseases and allergy disorders, and growing funding from the government for innovative therapies for yeast infections.

Q4. What are the major segments for yeast infection treatment market?

Answer: The future of the global yeast infection treatment market looks promising with opportunities in the retail pharmacy/drug store, hospital pharmacy, specialty store, and online sale markets.

Q5. Who are the key yeast infection treatment market companies?

Answer: Some of the key yeast infection treatment companies are as follows:

  • Astellas Pharma
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories
  • Bayer
  • Corden Pharma
  • Merck & Co
  • Novartis
  • Pfizer

Q6. Which yeast infection treatment market segment will be the largest in future?

Answer: Lucintel forecasts that tablets/capsule will remain the largest segment over the forecast period because they come in various sizes and have a longer shelf life.

Q7. In yeast infection treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in the frequency of vaginal infections and yeast infections in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the yeast infection treatment market by treatment type (azoles, polygene, echinocandin, and others), indication (genital candidiasis, invasive candidiasis, oropharyngeal/esophageal candidiasis, and others), form (powders, creams/ointments, tablets/capsules, and others), distribution channel (retail pharmacies/drug stores, hospital pharmacies, specialty stores, online sales, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Yeast Infection Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Yeast Infection Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Yeast Infection Treatment Market by Treatment Type
    • 3.3.1: Azoles
    • 3.3.2: Polygene
    • 3.3.3: Echinocandin
    • 3.3.4: Others
  • 3.4: Global Yeast Infection Treatment Market by Indication
    • 3.4.1: Genital Candidiasis
    • 3.4.2: Invasive Candidiasis
    • 3.4.3: Oropharyngeal/Esophageal Candidiasis
    • 3.4.4: Others
  • 3.5: Global Yeast Infection Treatment Market by Form
    • 3.5.1: Powders
    • 3.5.2: Creams/Ointments
    • 3.5.3: Tablets/Capsules
    • 3.5.4: Others
  • 3.6: Global Yeast Infection Treatment Market by Distribution Channel
    • 3.6.1: Retail Pharmacies/Drug Stores
    • 3.6.2: Hospital Pharmacies
    • 3.6.3: Specialty Stores
    • 3.6.4: Online Sales
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Yeast Infection Treatment Market by Region
  • 4.2: North American Yeast Infection Treatment Market
    • 4.2.1: North American Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.2.2: North American Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.3: European Yeast Infection Treatment Market
    • 4.3.1: European Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.3.2: European Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.4: APAC Yeast Infection Treatment Market
    • 4.4.1: APAC Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.4.2: APAC Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others
  • 4.5: ROW Yeast Infection Treatment Market
    • 4.5.1: ROW Yeast Infection Treatment Market by Form: Powders, Creams/Ointments, Tablets/Capsules, and Others
    • 4.5.2: ROW Yeast Infection Treatment Market by Distribution Channel: Retail Pharmacies/Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Yeast Infection Treatment Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Yeast Infection Treatment Market by Indication
    • 6.1.3: Growth Opportunities for the Global Yeast Infection Treatment Market by Form
    • 6.1.4: Growth Opportunities for the Global Yeast Infection Treatment Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Yeast Infection Treatment Market by Region
  • 6.2: Emerging Trends in the Global Yeast Infection Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Yeast Infection Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Yeast Infection Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Astellas Pharma
  • 7.2: Astra Zeneca
  • 7.3: Abbott Laboratories
  • 7.4: Allergan
  • 7.5: Brundavan Laboratories
  • 7.6: Bayer
  • 7.7: Corden Pharma
  • 7.8: Merck & Co
  • 7.9: Novartis
  • 7.10: Pfizer